FORT LAUDERDALE, FL / ACCESS Newswire / July 2, 2025 / Sunshine Biopharma Inc. (NASDAQ
BFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched NIOPEG\u00ae, the Company's first Biosimilar drug on the market. NIOPEG\u00ae is a Biosimilar comparable to the reference biologic drug NEULASTA\u00ae (Pegfilgrastim).
